Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Postulating the possible cellular signalling mechanisms of antibody drug conjugates in Alzheimer's disease
Prashanth Punyakoti, Tapan Behl, Aayush Sehgal, et al.
Cellular Signalling (2022) Vol. 102, pp. 110539-110539
Closed Access | Times Cited: 14

Showing 14 citing articles:

Second-generation anti-amyloid monoclonal antibodies for Alzheimer’s disease: current landscape and future perspectives
Byeong‐Hyeon Kim, Sujin Kim, Yunkwon Nam, et al.
Translational Neurodegeneration (2025) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Antibody–drug conjugates in cancer therapy: mechanisms and clinical studies
Jun He, Xianghua Zeng, Chunmei Wang, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 5
Pre/postnatal taurine supplementation improves neurodevelopment and brain function in mice offspring: A persistent developmental study from puberty to maturity
Mohammad Mehdi Ommati, Heresh Rezaei, Retana-Márquez Socorro, et al.
Life Sciences (2023) Vol. 336, pp. 122284-122284
Closed Access | Times Cited: 9
Synthesis and biological evaluation of novel zinc (II) and nickel (II) phthalocyanines as cholinesterase inhibitors
Didem Akkaya, Burak Barut, Suat Sarı, et al.
Journal of Organometallic Chemistry (2023) Vol. 995, pp. 122742-122742
Closed Access | Times Cited: 8
Antibody–drug conjugates: prospects for the next generation
Meriem Grairi, Marc Le Borgne
Drug Discovery Today (2024) Vol. 29, Iss. 12, pp. 104241-104241
Open Access | Times Cited: 2
Optimizing Conjugation Chemistry, Antibody Conjugation Site, and Surface Density in Antibody–Nanogel Conjugates (ANCs) for Cell-Specific Drug Delivery
Peidong Wu, Theeraphop Prachyathipsakul, Uyen Huynh, et al.
Bioconjugate Chemistry (2023)
Closed Access | Times Cited: 6
Monoclonal antibodies for the management of central nervous system diseases: clinical success and future strategies
Avtar Singh Gautam, Shivam Kumar Pandey, Vaibhav Lasure, et al.
Expert Opinion on Biological Therapy (2023) Vol. 23, Iss. 7, pp. 603-618
Closed Access | Times Cited: 6
A comprehensive review on the progress and challenges of tetrahydroisoquinoline derivatives as a promising therapeutic agent to treat Alzheimer's disease
Danesh Thangeswaran, Shaharum Shamsuddin, Venugopal Balakrishnan
Heliyon (2024) Vol. 10, Iss. 10, pp. e30788-e30788
Open Access | Times Cited: 1
Therapeutic induction of ferroptosis in tumors using PD-L1 targeting antibody nanogel conjugates
Mengdie Wang, Theeraphop Prachyathipsakul, Christi Wisniewski, et al.
Cell chemical biology (2024)
Closed Access | Times Cited: 1
Pyrrolobenzodiazepines: natural sources, therapeutic uses, and future in neurological treatments
Hadi Obaji, Abbas Gholipour Shilabin, Soumyajit Majumdar, et al.
Medicinal Chemistry Research (2023) Vol. 33, Iss. 1, pp. 36-46
Closed Access | Times Cited: 2
Emerging Novel Therapeutic Approaches for the Treatment of Alzheimer’s Disease
Amit Panwar, Mohd. Imran K. Khan, Rajesh Kumar, et al.
Advances in Alzheimer s Disease (2024) Vol. 13, Iss. 03, pp. 65-94
Open Access
AlzyFinder: A Machine-Learning-Driven Platform for Ligand-Based Virtual Screening and Network Pharmacology
Jessica Valero-Rojas, Camilo Andrés Ramírez-Sánchez, Laura Pacheco-Paternina, et al.
Journal of Chemical Information and Modeling (2024)
Closed Access
NSPCs-ES: mechanisms and functional impact on central nervous system diseases
Yu Si, Muhammad Abid Hayat, Jiabo Hu
Biomedical Materials (2024) Vol. 19, Iss. 4, pp. 042011-042011
Closed Access
Anti-amyloid Monoclonal Antibodies in Alzheimer’s Disease: A New Hope
Aygun Nasibova, Rovshan Khalilov, Aziz Eftekhari
International Journal of Aging (2023) Vol. 1, pp. e21-e21
Open Access
Page 1

Scroll to top